These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 8075592)

  • 61. Clinical promise of new hematopoietic growth factors: M-CSF, IL-3, IL-6.
    Garnick MB; O'Reilly RJ
    Hematol Oncol Clin North Am; 1989 Sep; 3(3):495-509. PubMed ID: 2698879
    [TBL] [Abstract][Full Text] [Related]  

  • 62. The role of hematopoietic growth factors in transfusion medicine.
    Whitsett CF
    Hematol Oncol Clin North Am; 1995 Feb; 9(1):23-68. PubMed ID: 7737944
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Abrogation of the hematological and biological activities of the interleukin-3/granulocyte-macrophage colony-stimulating factor fusion protein PIXY321 by neutralizing anti-PIXY321 antibodies in cancer patients receiving high-dose carboplatin.
    Miller LL; Korn EL; Stevens DS; Janik JE; Gause BL; Kopp WC; Holmlund JT; Curti BD; Sznol M; Smith JW; Urba WJ; Donegan SE; Watson TM; Longo DL
    Blood; 1999 May; 93(10):3250-8. PubMed ID: 10233876
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Binding, internalization and degradation of radio-iodinated interleukin 3 and granulocyte-macrophage colony stimulating factor by various hemopoietic cells.
    Péléraux A; Eliason JF; Odartchenko N
    Biochim Biophys Acta; 1990 Nov; 1055(2):141-50. PubMed ID: 2146975
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Expression and modulation of IL-3 and GM-CSF receptors in human growth factor dependent leukaemic cells.
    Brizzi MF; Avanzi GC; Veglia F; Clark SC; Pegoraro L
    Br J Haematol; 1990 Oct; 76(2):203-9. PubMed ID: 2151248
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Prediction of the role of granulocyte-macrophage colony-stimulating factor in animals and man from in vitro results.
    Liehl E; Hildebrandt J; Lam C; Mayer P
    Eur J Clin Microbiol Infect Dis; 1994; 13 Suppl 2():S9-17. PubMed ID: 7875154
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Interleukin 3 alone and in combination with GM-CSF in the treatment of patients with neoplastic disease.
    Hoelzer D; Seipelt G; Ganser A
    Semin Hematol; 1991 Apr; 28(2 Suppl 2):17-24. PubMed ID: 2063221
    [No Abstract]   [Full Text] [Related]  

  • 68. Clinical applications of colony-stimulating factors.
    Griffin JD
    Oncology (Williston Park); 1988 Jan; 2(1):15-23. PubMed ID: 3079316
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Interaction of GM-CSF and IL-3 with the common beta-chain of their receptors.
    Bagley CJ; Woodcock JM; Hercus TR; Shannon MF; Lopez AF
    J Leukoc Biol; 1995 May; 57(5):739-46. PubMed ID: 7759954
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Adjuvant therapy with recombinant interleukin-3 and granulocyte-macrophage colony-stimulating factor.
    Schulz G; Krumwieh D; Oster W
    Pharmacol Ther; 1991 Oct; 52(1):85-94. PubMed ID: 1805248
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Effects of interleukin-3 and granulocyte-macrophage colony-stimulating factor on thrombopoiesis in congenital amegakaryocytic thrombocytopenia.
    Guinan EC; Lee YS; Lopez KD; Kohler S; Oette DH; Bruno E; Kozakewich H; Nathan DG; Hoffman R
    Blood; 1993 Apr; 81(7):1691-8. PubMed ID: 8461459
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Human hematopoietic growth factors: old lessons and new perspectives.
    Dempke W; Von Poblozki A; Grothey A; Schmoll HJ
    Anticancer Res; 2000; 20(6D):5155-64. PubMed ID: 11326688
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Effect of the immunomodulator AS101 on chemotherapy-induced multilineage myelosuppression, thrombocytopenia, and anemia in mice.
    Kalechman Y; Rushkin G; Nerubay J; Albeck M; Sredni B
    Exp Hematol; 1995 Dec; 23(13):1358-66. PubMed ID: 7498364
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Interleukin 3: biological and clinical effects.
    Oster W; Schulz G
    Int J Cell Cloning; 1991 Jan; 9(1):5-23. PubMed ID: 2010655
    [No Abstract]   [Full Text] [Related]  

  • 75. Pleiotropic effects of cytokines: clinical and preclinical studies.
    Bukowski RM; Olencki T; McLain D; Finke JH
    Stem Cells; 1994; 12 Suppl 1():129-40; discussion 140-1. PubMed ID: 7696957
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Structure-function relationships of interleukin-3. An analysis based on the function and binding characteristics of a series of interspecies chimera of gibbon and murine interleukin-3.
    Kaushansky K; Shoemaker SG; Broudy VC; Lin NL; Matous JV; Alderman EM; Aghajanian JD; Szklut PJ; VanDyke RE; Pearce MK
    J Clin Invest; 1992 Nov; 90(5):1879-88. PubMed ID: 1385477
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Combination protocols of cytokine therapy with interleukin-3 and granulocyte-macrophage colony-stimulating factor in a primate model of radiation-induced marrow aplasia.
    Farese AM; Williams DE; Seiler FR; MacVittie TJ
    Blood; 1993 Nov; 82(10):3012-8. PubMed ID: 8219192
    [TBL] [Abstract][Full Text] [Related]  

  • 78. GM-CSF in marrow transplantation.
    Antman KH
    Eur J Cancer; 1993; 29A Suppl 3():S2-6. PubMed ID: 8398365
    [TBL] [Abstract][Full Text] [Related]  

  • 79. PIXY 321 (GM-CSF/IL-3 fusion protein).
    Secola R
    J Pediatr Oncol Nurs; 1993 Jul; 10(3):117-8. PubMed ID: 8397971
    [No Abstract]   [Full Text] [Related]  

  • 80. Cytokine stimulation of multilineage hematopoiesis from immature human cells engrafted in SCID mice.
    Lapidot T; Pflumio F; Doedens M; Murdoch B; Williams DE; Dick JE
    Science; 1992 Feb; 255(5048):1137-41. PubMed ID: 1372131
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.